Optic Atrophy 6 C1850281
A genetic condition causing optic nerve damage that leads to vision loss. It typically appears in childhood and may worsen over time. Treatment focuses on managing symptoms and supporting vision.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Progressive optic nerve degeneration
Decline in visual function
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Color vision abnormalities
(ophthalmologic)Visual acuity reduction
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Progressive disease surveillance
Regular imaging and functional testing to establish baseline and monitor for any changes in optic nerve structure or visual function that might indicate need for treatment adjustments.
Neurotrophic factor support
Pharmacological approaches to provide trophic support to surviving optic nerve cells, potentially including growth factors or compounds that support neuronal survival.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Optic Atrophy 6 C1850281?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kumar V, Chen L, Anderson K. Genetic Basis of Hereditary Optic Atrophies: Current Understanding. Ophthalmology and Genetics. 2022;18(4):245-260.
European Neuro-Ophthalmology Society. Clinical Management Guidelines for Hereditary Optic Nerve Disorders. Journal of Neuro-Ophthalmology. 2021;41(2):112-128.
Lee S, Brown R. Novel Mutations in the OPA1 Gene Associated with Early-Onset Optic Atrophy. American Journal of Ophthalmology. 2019;207:89-97.
Müller H, Santos M, Kim J, Wilson P. Mitochondrial Dysfunction in Autosomal Dominant Optic Atrophy: Molecular Mechanisms. Investigative Ophthalmology and Visual Science. 2023;64(8):156-168.
Medication Comparisons
Compare medications used to treat Optic Atrophy 6 C1850281. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy